Patents Assigned to IsoPlexis Corporation
  • Patent number: 11940413
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. A plurality of smaller flow cells is employed, each with a relatively small area to be imaged, in order to provide greater flexibility and efficiency.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: March 26, 2024
    Assignee: IsoPlexis Corporation
    Inventors: Steven Gordon, Thomas Hagerott, Edmund Golaski, Jerzy Olejnik
  • Patent number: 11866741
    Abstract: The present invention relates to a polymerase enzyme from 9° N with improved ability to incorporate reversibly terminating nucleotides. The enzyme comprising mutations in the motif A region. The invention also relates to methods of using such enzymes as well as a kit with such polymerases.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: January 9, 2024
    Assignee: IsoPlexis Corporation
    Inventors: Jerzy Olejnik, Angela Delucia
  • Patent number: 11821032
    Abstract: The present invention provides methods, compositions, mixtures and kits utilizing 5-Chloro-2-methyl-4-isothiazolin-3-one in sequencing reactions, and in particular, sequencing reactions where deoxynucleoside triphosphates comprising a 3?-O position capped by a disulfide-based 3?-terminator group are used. In one embodiment, the deoxynucleoside triphosphates comprise a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. In addition, thiol-containing compounds and scavengers of thio-containing compounds are described. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: November 21, 2023
    Assignee: IsoPlexis Corporation
    Inventors: Luisa Andruzzi, Jimmy Adediran, Timothy Pelletier, Austin Ricker, Angela DeLucia, Ben McNally, Dona Hevroni, Mong Sano Marma, John Andrew Sheridan
  • Patent number: 11661619
    Abstract: Embodiments disclose apparatus, methods and software for performing biological screening and analysis implemented using an instrument platform capable of detecting a wide variety of cell-based secretions, expressed proteins, and other cellular components. The platform may be configured for simultaneous multiplexed detection of a plurality biological components such that a large number of discrete samples may be individually sequestered and evaluated to detect or identify constituents from the samples in a highly parallelized and scalable manner.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: May 30, 2023
    Assignee: IsoPlexis Corporation
    Inventors: Patrick Paczkowski, Sean Mackay, Sean McCusker
  • Patent number: 11548909
    Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: January 10, 2023
    Assignee: IsoPlexis Corporation
    Inventors: Mong Sano Marma, Jerzy Olejnik, Ilia Korboukh
  • Patent number: 11525783
    Abstract: Embodiments of the current disclosure are directed to systems, methods and apparatus for evaluating single cell secretion profiles. In some embodiments, the apparatus may be configured to analyze substances expressed by a biological cell and may include a first compressible substrate, and a second substrate configured for removable sealing attachment with the first substrate. In some embodiments, upon attachment of the second substrate with the first substrate, an assembly is formed such that the open side of the plurality of chambers are covered by the second substrate, and a portion of each of the plurality of capture areas are exposed in each of the chambers.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: December 13, 2022
    Assignee: IsoPlexis Corporation
    Inventors: Peter Tsiomplikas, Jerry Sedgewick, Jeffrey Whynall, Sean MacKay, Colin Ng, Patrick Paczkowski, Sean McCusker, Igor Nikonorov, Alaina Kaiser
  • Patent number: 11493508
    Abstract: Disclosed are compositions and methods for the multiplexed analysis of one or more intracellular targets of a single cell. Exemplary compositions of the disclosure comprise a surface comprising a plurality of capture agents operatively-linked thereto, wherein each capture agent specifically binds to a distinct intracellular target and wherein the plurality of capture agents form a repeating pattern; a substrate comprising a plurality of chambers, wherein the substrate releasably couples with the surface and wherein each chamber of the plurality of chambers comprises at least one repeat of the repeating pattern of the plurality of capture agents of the surface; a coating composition comprising a cell lysis composition; and a linker composition comprising a functionalization component and an extension component.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: November 8, 2022
    Assignee: IsoPlexis Corporation
    Inventors: Colin Ng, Alaina Kaiser, Emily Bettini, Patrick Paczkowski, Sean Mackay, Feimei Liu, Maithreyan Srinivasan
  • Patent number: 11421264
    Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. In addition, thiol-containing compounds and scavengers of thio-containing compounds are described. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: August 23, 2022
    Assignee: IsoPlexis Corporation
    Inventors: Mong Sano Marma, Luisa Andruzzi, Ben McNally, Angela DeLucia, Dona Hevroni, Elizabeth Carpenter, Magnus Besev
  • Patent number: 11162129
    Abstract: The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of photoprotective mixture of compounds as imaging reagents to improve stability and storage of fluorescent compounds, including but not limited to, nucleotides with fluorescent labels.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: November 2, 2021
    Assignee: IsoPlexis Corporation
    Inventors: Luisa Andruzzi, Michel Georges Perbost, Dona Hevroni, Minakshi Guha, Austin Ricker, Timothy Pelletier
  • Patent number: 11149309
    Abstract: The present invention relates to methods and devices for amplifying nucleic acid, and, in particular, amplifying so as to generate products on a surface without the use of emulsions. In a preferred embodiment, a plurality of groups of amplified product are generated on the surface, each group positioned in different (typically predetermined) locations on said surface so as to create an array.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: October 19, 2021
    Assignee: IsoPlexis Corporation
    Inventors: Steven Gordon, Daniel Stetson
  • Patent number: 11117921
    Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: September 14, 2021
    Assignee: IsoPlexis Corporation
    Inventors: Mong Sano Marma, Jerzy Olejnik, Ilia Korboukh
  • Patent number: 11078526
    Abstract: The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of polyphenolic compounds, known as antioxidant additives, to improve the efficiency of Sequencing-By-Synthesis reactions. For example, gallic acid (GA) is shown herein to be one of many exemplary SBS polyphenolic additives.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: August 3, 2021
    Assignee: IsoPlexis Corporation
    Inventors: Jerzy Olejnik, Michel Georges Perbost
  • Patent number: 11066689
    Abstract: Embodiments disclose apparatus, methods and software for performing biological screening and analysis implemented using an instrument platform capable of detecting a wide variety of cell-based secretions, expressed proteins, and other cellular components. The platform may be configured for simultaneous multiplexed detection of a plurality biological components such that a large number of discrete samples may be individually sequestered and evaluated to detect or identify constituents from the samples in a highly parallelized and scalable manner.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: July 20, 2021
    Assignee: IsoPlexis Corporation
    Inventors: Patrick Paczkowski, Sean MacKay, Sean McCusker
  • Patent number: 10584366
    Abstract: Embodiments disclose apparatus, methods and software for performing biological screening and analysis implemented using an instrument platform capable of detecting a wide variety of cell-based secretions, expressed proteins, and other cellular components. The platform may be configured for simultaneous multiplexed detection of a plurality biological components such that a large number of discrete samples may be individually sequestered and evaluated to detect or identify constituents from the samples in a highly parallelized and scalable manner.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: March 10, 2020
    Assignee: IsoPlexis Corporation
    Inventors: Patrick Paczkowski, Sean MacKay, Sean McCusker
  • Publication number: 20190376898
    Abstract: Embodiments of the current disclosure are directed to systems, methods and apparatus for evaluating single cell secretion profiles. In some embodiments, the apparatus may be configured to analyze substances expressed by a biological cell and may include a first compressible substrate, and a second substrate configured for removable sealing attachment with the first substrate. In some embodiments, upon attachment of the second substrate with the first substrate, an assembly is formed such that the open side of the plurality of chambers are covered by the second substrate, and a portion of each of the plurality of capture areas are exposed in each of the chambers.
    Type: Application
    Filed: November 22, 2017
    Publication date: December 12, 2019
    Applicant: IsoPlexis Corporation
    Inventors: Peter TSIOMPLIKAS, Jerry SEDGEWICK, Jeffrey WHYNALL, Sean MACKAY, Colin NG, Patrick PACZKOWSKI, Sean MCCUSKER, Igor NIKONOROV, Alaina KAISER
  • Publication number: 20190285626
    Abstract: Disclosed are compositions and methods for the multiplexed analysis of one or more intracellular targets of a single cell. Exemplary compositions of the disclosure comprise a surface comprising a plurality of capture agents operatively-linked thereto, wherein each capture agent specifically binds to a distinct intracellular target and wherein the plurality of capture agents form a repeating pattern; a substrate comprising a plurality of chambers, wherein the substrate releasably couples with the surface and wherein each chamber of the plurality of chambers comprises at least one repeat of the repeating pattern of the plurality of capture agents of the surface; a coating composition comprising a cell lysis composition; and a linker composition comprising a functionalization component and an extension component.
    Type: Application
    Filed: November 13, 2017
    Publication date: September 19, 2019
    Applicant: IsoPlexis Corporation
    Inventors: Colin NG, Alaina KAISER, Emily BETTINI, Patrick PACZKOWSKI, Sean MACKAY, Feimei LIU, Maithreyan SRINIVASAN